REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/30/2026
Back to search
Official data from USPTO
DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
03/31/2026
Trademark type
Combined
Nice classes
35, 36
Filing date
09/28/2020
Registration date
03/30/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/30/2021
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/30/2019
First use in commerce
07/30/2019
Drawing code
3
Owner type
99
Owner location
Leverusen, DE
Examiner
RICHARDS, LESLIE
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "DUDE" with a curved line and a dot over the second "D". Below the word "DUDE" is the phrase "ACCESS SERVICES" and below that is the phrase "Darolutamide User Drug Experience".
Holders and representatives
Holders
B. A. (pessoa física)
Representatives
Phillip Barengolts Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP
Technical classification
Nice Classes
Class 35Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business administration of patient reimbursement programs; Business administration of pharmaceutical reimbursement programs and services; Business management of reimbursement programs for others; Strategic business planning and consultation in the field of reimbursement support for pharmaceutical products; Business administration of support programs for patients to access co-pay assistance and other funding sources to pay for specialty medications
Class 36
Financial administration of health reimbursement arrangements; Financial management of reimbursement payments for others; Financial administration of medication reimbursement programs and services; Financial administration of patient reimbursement programs to provide medical insurance copay assistance to eligible patients to reduce the cost; Providing patients who have been prescribed a specific course of therapy that involves prescription pharmaceuticals with information on medical insurance coveragepatient reimbursement options and financial support for that therapy; Prescription drug claims administration servicesfacilitating authorization of health care insurance coverageinsurance claim submission and payer reimbursement for prescription drugs
Publications
History of USPTO decisions and trademark events.
13 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/17/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/17/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/30/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/12/2021
PUBO
PUBLISHED FOR OPPOSITION
01/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/23/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/2020
DOCK
ASSIGNED TO EXAMINER
12/02/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2020
NWAP
NEW APPLICATION ENTERED
10/01/2020
Continuous trademark protection
Get notified about every new filing that threatens DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG EXPERIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.